The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Thanx for your advice but I will stick to my conclusions.
Herman I would save your money for a few weeks. After the placing you'll likely to be able to get twice as much for the same money
I have a feeling, just my opinion, that the recent RNS's are about getting the price up to get a placing away.
The Twitterarti will tell you the last placing was at 14p, will be interesting to see what they can get the next placing away at
When's the next fundraise?
Good RNS. I managed to top up at 7.08p.
...passes back the concerns expressed here. Not sure what yesterdays RNS was supposed to achieve, as yet again, in my opinion, it read like another attempt to simply promote the company rather than inform the market. Interesting part was "The more detailed experimental results remain under embargo pending publication at a leading cancer research conference." Making the claim that they do have results but they are embargoed, which still means they haven't released any data for peer review.
Again ROQ informed us of how much they feel the various markets are worth by listing an articles from Yahoo Finance and barchart.com, I'm not sure if they are credible sources of market data?????
Again the best they have told us, in my opinion, is that certain things are "statistically significant" in a test tube. Correct me if I'm wrong.
And so the talking continues and still nothing released to be peer reviewed.
Edenville, soon to be Shuka Resources, is at a very important inflection point. Having averaged down over the years I'm poised and happy with the state of play.
I agree moneybags, any big pharma doing their due diligence on ROQ and Ajan should certainly look at the 15 years of data Ajan professes to have and whether that includes data from the Greek trials. Nothing has been published. Why not?
The more I read on Elizabeth Holmes and Theranos, the more I worry about ROQ.
watch edl very carefully by the way ... jason brewer and qglobals *****on vd burgh have taken big stakes recently and i think we are going to see exciting developments imminently.
back to roq .... i remain concerned that none of their exciting looking projects have been published, even in basic science journals, let along oncology / medical journals ... and until there is something more substantial to digest i remain an interested bystander
Well you've wasted atleast 5 years of your life invested in a turd. So you're obviously not as clued on as you think, because if you were you wouldn't be holding EDL. I'm guessing your average is in the triple digits. Good luck
My average is my average, I'm not going to post details such as that and you won't find many stoopid enough to post their average. You can think what you like, you have no idea what I'm invested in or at what price, nor do you need to know, but you are 5% down in ROQ.
"Why have you been posting on that bulletin board since at least 2018?" Because I want to!! FFS, please just go back to Twitter and repost a few more of your mates tweets.
What price are you in EDL? Why have you been posting on that bulletin board since atleast 2018?
keep posting watermelon mate, all the ****e your coming out with tells people more about you than it does me.
like i say, stick to twitter.
Would have told you to watch the Killing too but you have been an EDL shareholder for 5 years, you've seen your fair share of a killing
Yes I am down but by about 5%. How much are you down on EDL? 95%? Why are you still in that turd
Stick to watching season one of The Killing mate.
How would you even know what I'm invested in? Do you post on every board you're invested in?
Run along, probably best you stick to twitter.
Watermelon,
The answer is no, but I'm guessing you're down big time in roq.
Wow just seen that you have been switching between an EDL shareholder for over 5 years. The share price is down 96% since then. And you're investment in OEX (now SYN) isn't going great either. Are you stuck in both of them?
Sausage for someone who isn't invested in ROQ you spend an awful long time on this board, perhaps concentrate on your investments in EDL and SYN?
...presentations at conferences rather than releasing the data to be peer reviewed that's the worry for me.
Interesting reads
https://www.businessinsider.com/theranos-used-its-scientific-conference-presentation-to-unveil-its-new-products-and-people-werent-loving-it-2016-8?r=US&IR=T
https://www.fiercebiotech.com/medical-devices/theranos-finally-presents-data-but-answers-no-questions
https://uk.sports.yahoo.com/news/one-during-theranos-presentation-yesterday-181300473.html
https://arstechnica.com/science/2016/08/elizabeth-holmes-is-finally-presenting-theranos-data-as-company-collapses/
In simpler terms, the company has developed a program called the MDK mRNA, which they've tested on breast and liver cancer cells in laboratory conditions (in vitro). Their aim was to see if the program could slow the growth and spread (or migration) of these cancer cells, which could be an early indicator of whether it might prevent the spread of cancer in the body (metastasis).
The results of these laboratory tests were very positive, showing a significant decrease in both the growth and the spread of the cancer cells. However, it's important to note that these are still early findings and they've only been observed in a controlled lab environment, not in actual patients (clinical trials).
If these effects can be reproduced in clinical trials, the MDK mRNA Program could potentially be the first of its kind in cancer medicine, representing a significant breakthrough.
The company is planning to share these promising initial results at a major upcoming cancer conference.
Very rarely do you see data on these early stage projects, it’s simply not how they work. Interest will build and data gets released to potential licensing partners on request (which nearly always remains unnamed) and could go into early stage commercial agreements. It’s very basic bence work completed but still shows stage work proof of concept.. it’s a sub £10m company, they ain’t gonna go big bananas on advertising, yet..
In vivo will be a completely different story, higher risks involved but it’ll be a fantastic hurdle once completed and I feel the SP will reward that news with far more pharma investors taking longer positions.
Best of luck